African trypanosomiasis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
m Changes made per Mahshid's request |
Category |
||
Line 10: | Line 10: | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Neurology]][[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | [[Category:Neurology]] |
Revision as of 20:55, 20 September 2017
African trypanosomiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
African trypanosomiasis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of African trypanosomiasis cost-effectiveness of therapy |
FDA on African trypanosomiasis cost-effectiveness of therapy |
CDC on African trypanosomiasis cost-effectiveness of therapy |
African trypanosomiasis cost-effectiveness of therapy in the news |
Blogs on African trypanosomiasis cost-effectiveness of therapy |
Risk calculators and risk factors for African trypanosomiasis cost-effectiveness of therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.